coremedic.de bewertung und analyse

Robots.txt Information
Robot Path Permission
GoogleBot /
BingBot /
BaiduSpider /
YandexBot /
User-agent: *
Allow: /
# Optimization for Google Ads Bot
User-Agent: AdsBot-Google-Mobile
User-Agent: AdsBot-Google
Disallow: /_api/*
Disallow: /_partials*
Disallow: /pro-gallery-webapp/v1/galleries/*
Meta Tags
Title About Us | CoreMedic GmbH | TMVr | Radolfzell am Bodensee,
Description FIRST LINE TREATMENT FOR  MITRAL VALVE CoreMedic GmbH - ChordArt TMVr - First Line Treatment for Mitral Valve
Keywords N/A
Server Information
WebSite coremedic faviconcoremedic.de
Host IP 185.230.63.186
Location -
Mehr zu entdecken
Site
farie.ch
filmzimmer.ch
greenlightvision.ch
hautarztdonaueschingen.de
ks-info.com
kuther.de
laermliga.ch
makemymosaic.ch
malergeschaeft-schibli.ch
mininavident.com
mz-buchhaltung.ch
optor.ch
private-sales-club.com
tamiforfit.com
thuer-personal.ch
coremedic.de bewertung
Euro3,306
Zuletzt aktualisiert: 2022-09-24 12:53:51

coremedic.de hat Semrush globalen Rang von 8,070,156. coremedic.de hat einen geschätzten Wert von € 3,306, basierend auf seinen geschätzten Werbeeinnahmen. coremedic.de empfängt jeden Tag ungefähr 551 einzelne Besucher. Sein Webserver befindet sich in - mit der IP-Adresse 185.230.63.186. Laut SiteAdvisor ist coremedic.de sicher zu besuchen.

Verkehr & Wertschätzungen
Kauf-/Verkaufswert Euro€3,306
Tägliche Werbeeinnahmen Euro€98,078
Monatlicher Anzeigenumsatz Euro€33,060
Jährliche Werbeeinnahmen Euro€2,204
Tägliche eindeutige Besucher 551
Hinweis: Alle Traffic- und Einnahmenwerte sind Schätzungen.
DNS Records
Host Type TTL Data
coremedic.de. A 3600 IP: 185.230.63.186
coremedic.de. A 3600 IP: 185.230.63.107
coremedic.de. A 3600 IP: 185.230.63.171
coremedic.de. NS 86400 NS Record: ns6.wixdns.net.
coremedic.de. NS 86400 NS Record: ns7.wixdns.net.
coremedic.de. MX 3600 MX Record: 5 mta-gw.infomaniak.ch.
HtmlToTextCheckTime:2022-09-24 12:53:51
About Us Mitral Valve Regurgitation ChordArt People News / Resources Contact COREMEDIC GMBH An innovative cardiology company CoreMedic was initiated in 2012 as a spin-out of the Heart Center of University of Bern, Switzerland, in order to develop an innovative treatment concept for mitral valve regurgitation (MR). The initiators of CoreMedic had a simple but challenging idea: to combine the least invasive treatment option for MR, replacement of mitral chords, and the least invasive operational procedure into one new system: ChordArt. ​ In 2014, CoreMedic became operational as an independent entity with own management and facilities. ​ In 2017, the development of ChordArt had progressed towards first use in a human trial, enabling CoreMedic to attract institutional financing. The company moved to RIZ-innovation center at Radolfzell, Germany, located at Lake Constance close to the Swiss border within the leading medical technology cluster of Tuttlingen, Germany. ​ Following successful
HTTP Headers
HTTP/1.1 301 Moved Permanently
Date: Fri, 07 Jan 2022 09:29:55 GMT
Content-Length: 0
Connection: keep-alive
location: https://www.coremedic.de/
strict-transport-security: max-age=120
Age: 3828
Server-Timing: cache;desc=hit, varnish;desc=hit, dc;desc=84
X-Seen-By: RQvnDyN5n1orR2cJk2hJbg==,sHU62EDOGnH2FBkJkG/Wx8EeXWsWdHrhlvbxtlynkVjIPSNDCPxQDxXcGwivWl4N,m0j2EEknGIVUW/liY8BLLtxbqKixcgheJzihIl22fmTJftmKrOReD3ukbbas4YDo,2d58ifebGbosy5xc+FRalpL5yUCkuz0kV1mKyKs5IiGTkxU/MyCd14J2/cNTdAIxWsZ2mRPn+njH1uvC1WyGDw==,2UNV7KOq4oGjA5+PKsX47FWQphhqZlrQzn660S24P+W8ZDY613cHYLbuhNMgAom1
Cache-Control: no-cache
X-Wix-Request-Id: 1641547795.646122501337442008
X-Content-Type-Options: nosniff

HTTP/2 200 
date: Fri, 07 Jan 2022 09:29:56 GMT
content-type: text/html; charset=UTF-8
link: ; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,; rel=preconnect; crossorigin;,; rel=preconnect;,; rel=preconnect; crossorigin;,
x-wix-request-id: 1641547795.94712455738529335
content-language: en
strict-transport-security: max-age=120
age: 0
x-seen-by: GXNXSWFXisshliUcwO20NXdyD4zpCpFzpCPkLds0yMccjKj90N86+0CALAZ0kY4I,qquldgcFrj2n046g4RNSVCjKv9Ivm4B6dLRh6gIgi3s=,2d58ifebGbosy5xc+FRalt1mOrbNZTvPLm1ZJZZke3Emp2tlxSSfRvO9u0mZwQKz3QpI/ucnHvfrUjeESIoVeqkLxnNWNYvCxX+ZKFEvBFw=,2UNV7KOq4oGjA5+PKsX47Dup3Er3OeJdBpGMGRuuaaaa46R9xNIlpQ4eUPYpBuqs,FFlneJ0wr5RRBwVByc5mCF2Fz639Jru9lJTuuuFKXo3wcXiCJjelMQdweukbvEnQ,sqmudy1rWy5CXemzdhzS/EIO58Mf2Yq4tj5yDt1mZYlNG+KuK+VIZfbNzHJu0vJu,GiE5c8Q213kn1NHwElo57I8IIizZG/IBYvwRxxQsFamvMdYH7GbruDVmRSdmEW6/WIHlCalF7YnfvOr2cMPpyw==,sqmudy1rWy5CXemzdhzS/EIO58Mf2Yq4tj5yDt1mZYlNG+KuK+VIZfbNzHJu0vJu,LoUK8/saGAmOxZWtpubo2qYIe9Ki059BxfLBl7hr5TvvFXvRJpo3BqBonIaPumP/20L7EOHQBwbaNNGLN2WbFw==,l7Ey5khejq81S7sxGe5NkxAlxtS9Iv9fxBquuoEoMyuTzRA6xkSHdTdM1EufzDIPWIHlCalF7YnfvOr2cMPpyw==,m7d0zj9X6FBqkyAIyh66vMnoFuVWl3b6T/nel/2wqR1NG+KuK+VIZfbNzHJu0vJu,/a5ccLSK1HEmwPNg/x6OusoyqqbDwMcPkYdqLRx9tWWrWFKmeoMDm55I2GVN28U0o4wJwt3yoPiqYtgMbCd4UQ==
cache-control: no-cache
vary: Accept-Encoding
accept-ranges: bytes
set-cookie: ssr-caching=cache#desc=miss#varnish=miss#dc#desc=eun1_g; Max-Age=20; Expires=Fri, 07 Jan 2022 09:30:16 GMT
server-timing: cache;desc=miss, varnish;desc=miss, dc;desc=eun1_g
x-content-type-options: nosniff
server: Pepyaka/1.19.10
via: 1.1 google
alt-svc: h3=":443"; ma=2592000,h3-29=":443"; ma=2592000,h3-Q050=":443"; ma=2592000,h3-Q046=":443"; ma=2592000,h3-Q043=":443"; ma=2592000,quic=":443"; ma=2592000; v="46,43"